Nomura Holdings »

Biomarin Pharmaceutical shares owned by Nomura Holdings

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Nomura Holdings from 13F filings

Historical chart of Nomura Holdings investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Nomura Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Nomura Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $443k 7.5k 59.43

More positions owned by Nomura Holdings

Echostar Corp Note 3.875%11/3
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Alibaba Group Hldg Note 0.500% 6/0
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Pepsi (PEP)
Dollar Tree (DLTR)
Palantir Technologies Cl A (PLTR)

View all positions for Nomura Holdings

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Lazard Asset Management
BlackRock
Man Group
Capstone Investment Advisors
MacKay Shields
Opti Capital Management
Millennium Management
Verition Fund Management
Oaktree Capital Management
Victory Capital Management
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Jpmorgan Chase & Co

View all funds holding Biomarin Pharmaceutical